Senators Launch Investigations on Orphan Drugs
Two groups of senators have launched investigations into orphan drugs to examine whether drugmakers are misusing the designation and overcharging for treatments.
Source: Drug Industry Daily
Two groups of senators have launched investigations into orphan drugs to examine whether drugmakers are misusing the designation and overcharging for treatments.
Source: Drug Industry Daily